Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study.

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

UMIN-CTR Trials Registry, UMIN000044126; registered 10 May 2021.

Keyphrases